SEMHF:OTC-Siemens Healthineers AG (USD)

COMMON STOCK | | OTC

Last Closing Price

USD 45.37

Change

0.00 (0.00)%

Market Cap

USD 44.82B

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company's Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The company's Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. Siemens Healthineers AG has a collaboration agreement with MicroPort Scientific Corp. to develop medical imaging equipment used in diagnostics and operating procedures. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-10-28 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABEC Analytica Bio-Energy Corp

N/A

USD790.71B 25.06 N/A
BTHI Big Time Holdings, Inc

N/A

USD151.65B N/A N/A
DFIFF Diamond Fields Resources Inc

N/A

USD46.92B 39.43 N/A
HENOF Henkel AG & Co. KGaA

N/A

USD44.03B 11.51 N/A
YACAF Yancoal Australia Ltd

N/A

USD41.57B 0.20 N/A
WXIBF WuXi Biologics (Cayman) Inc

-0.34 (-1.17%)

USD38.30B 203.76 28.08
HDALF Haidilao International Holding..

+0.20 (+2.92%)

USD36.50B 79.20 N/A
MQBKY Macquarie Group Limited

-4.64 (-4.83%)

USD35.53B 17.85 15.81
PETFF PTT Public Company Limited

N/A

USD34.53B 14.15 0.17
SUVPF Sartorius Aktiengesellschaft

-19.73 (-4.23%)

USD31.17B 125.35 N/A

ETFs Containing SEMHF

Symbol Name Weight Mer Price(Change) Market Cap
EGRA:LSE WisdomTree Issuer ICAV - .. 0.00 % 0.29 %

-0.57 (-3.14%)

USD0.02B
EGRP:LSE WisdomTree Eurozone Quali.. 0.00 % 0.29 %

-44.20 (-3.04%)

USD0.02B
EGRW:LSE WisdomTree Eurozone Quali.. 0.00 % 0.29 %

-0.51 (-3.14%)

USD0.02B
XDGM:LSE Xtrackers Germany Mittels.. 0.00 % 0.40 %

-0.79 (-3.33%)

USD0.07B

Market Performance

  Market Performance vs.
Industry/Classification ()
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.58% N/A N/A 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.58% N/A N/A 54% F
Trailing 12 Months  
Capital Gain 7.01% N/A N/A 62% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.01% N/A N/A 62% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.21% N/A N/A 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.21% N/A N/A 42% F
Risk Return Profile  
Volatility (Standard Deviation) 3.87% N/A N/A 97% A+
Risk Adjusted Return 31.28% N/A N/A 65% D
Market Capitalization 44.82B N/A N/A 98% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
()
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.69 N/A N/A 28% F
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 27.72 N/A N/A 6% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 16.05% N/A N/A 87% B+
Return on Invested Capital 12.26% N/A N/A 74% C
Return on Assets 6.22% N/A N/A 89% B+
Debt to Equity Ratio 41.66% N/A N/A 41% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.51 N/A N/A 66% D
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike